Category: Allies & Partnerships


Keeping You Connected to the Melanoma Community

By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 18 February 2020 In Allies & Partnerships

With the launch of the brand-new Inspire App, the Melanoma > Exchange community is getting even better. Available for iPhone and iPad – the app was designed from the ground up to make connecting and sharing even easier and as mobile as you are.

Read More


MRA is Raising the Treatment Bar

31 October 2019 In Allies & Partnerships, Melanoma Stories, Science, Treatment

We have made unprecedented progress that is transforming what it means to be diagnosed with melanoma. Today, we have more treatment options than ever before—in fact 12 new options have earned FDA approval since MRA's founding. But, it's still not enough.

Read More


SPORE Grants: Putting Collaboration Front & Center

By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 24 September 2019 In Allies & Partnerships, Science, Treatment

In medicine, sometimes the biggest and most game-changing advancements come from a single person – who through tireless work – arrives at a true ‘eureka’ moment. This ‘go it alone’ concept is not only reinforced through television and movies, it’s also bolstered in the way the medical community makes research...

Read More


Treating Melanoma Patients Before Surgery

3 September 2019 In Allies & Partnerships, Science, Treatment

Over 90% of patients who have their tumors surgically removed will never see their tumors come back or spread to other sites, but is there a way to prevent recurrence in those patients that will eventually go on to relapse? One approach currently being tested in clinical trials, termed neoadjuvant therapy, is to treat early stage patients with targeted or immunotherapy before surgical removal of their tumor.

Read More


Highlights from the 2019 Scientific Retreat

30 May 2019 In Allies & Partnerships, Events, Melanoma Stories, News, Prevention, Science, Treatment

Over the course of three days, MRA convened over 300 people from across the melanoma research community: patients, doctors, researchers, industry, and government. Participants discussed everything from new treatment approaches such as RNA-based vaccines, strategies to fight back against treatment resistance, and hurdles to testing neo-adjuvant therapies in melanoma.

Read More


Building Community While Raising More than $10 Million for Melanoma

By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 15 April 2019 In Allies & Partnerships, Events

Leveraged Finance Fights Melanoma has become an annual event that brings over 1,000 people together from the leveraged finance and private equity community. Cofounder Brendan Dillon shares his own journey with melanoma.

Read More


Make Your Sun Safety Habit Stick: La Roche Posay’s My Skin Track UV

By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 3 January 2019 In Allies & Partnerships, Prevention

Last month’s arrival of La Roche Posay’s My Skin Track UV may be just what the doctor ordered to help people understand the danger of overexposure to ultraviolet radiation.

Read More


Are you #SunSavvy365?

By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 4 September 2018 In Allies & Partnerships, Prevention

​It’s easy to think of sunscreen when you are lounging by a pool, but did you know that it’s important to protect yourself and those you love every day of the year? That’s why MRA partnered with the Melanoma Action Coalition to create #SunSavvy365, a social media campaign that reminds us to protect our skin whether we are making sand castles or snowmen.

Read More


Uveal ‘Clusters’ in Auburn, AL and Huntersville, NC

By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 18 July 2018 In Allies & Partnerships, Melanoma Stories, News, Science, Treatment

When we talk about melanoma, it’s easy to forget that cutaneous – the most common variety that forms on the skin – isn’t the only game in town. Uveal represents about 5% of all melanomas diagnosed each year. So, when dozens of people from two towns in North Carolina and Alabama were diagnosed with the rare cancer alarm bells sounded.

Read More


We’ve Teamed Up with the American Cancer Society

By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 7 June 2018 In Allies & Partnerships, Science, Treatment

American Cancer Society and Melanoma Research Alliance have united to fund lifesaving research aimed at reducing side effects and improving outcomes for patients treated with immunotherapy.

Read More


Login

×